AVDL vs ILMN · rev $169.1M vs rev $2.25B
Avadel Pharmaceuticals PLC (AVDL) versus Illumina Inc (ILMN) — a side-by-side from cached financials, not a winner call.
Avadel Pharmaceuticals PLC (AVDL) is a drug manufacturers - specialty & generic company listed on US.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Latest reported AVDL revenue for 2024-12-31 was $169.1M. Net income was -$48.8M. Revenue was up 504.8% from 2023-12-31 to 2024-12-31. AVDL currently screens at market cap $968.5M.
Latest reported ILMN revenue for 2026-06-28 was $2.25B. Net income was $340.0M. ILMN currently screens at market cap $15.84B.
AVDL currently screens at market cap $968.5M. ILMN currently screens at market cap $15.84B.
Not investment advice. Open the AVDL and ILMN stock pages for the full models.
Not investment advice.